MODERN HYBRID INTERVENTIONAL RADIOLOGY IN HEPATOLOGY

Abstract

By delivering image-guided, minimally invasive procedure, interventional radiology (IR) is transforming the landscape of hepatology rapidly by offering relief to complex liver diseases.  The research employs a mixed-methods methodology to examine the effectiveness of the process, the results of its clinical use, and the opinions of the experts regarding the use of IR in hepatologic interventions.  There were 150 patients having IR procedures such as TIPS, radiofrequency ablation, percutaneous biliary drainage, and portal vein embolization with cirrhosis and hepatocellular carcinoma (HCC) or portal hypertension.  Quantitative analysis demonstrated that the success rate of technical procedures was above 90 percent, the MELD scores were noted to have a great improvement after treatment, and the 90-day survival rate stood at 78 percent.  The KaplanMeier survival curves indicated that the drug became more effective with time and Cox regression revealed that MELD and INR were significant variables in survival duration of a patient.  Simultaneously, researchers conducted qualitative interviews of 18 hepatology and IR professionals that determined procedural trust, interdepartmental workflow, and institutional preparation as one of the most significant elements of clinical integration.  Thematic analysis revealed that human beings are getting more assuring about the use of IR as an up-front technology to address issues on liver care. It revealed that the access as well as training with different fields and communication existing between such field has issues.  Meta-inference integrated the two information feeds to provide an in-depth understanding of what IR contributions have been beyond being a technical innovation, but a strategic clinical ally in the field of hepatology.  This paper indicates that interventional radiology ought to play a major role in the treatment of liver disease. It also preconditions further clinical recommendations and training programs in the field of hybrid hepatologic treatment.